Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2019-03-29
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The necessary permissions have been obtained from the authors for Short BESTest, whose validity and reliability features will be tested, and the translation process to Turkish has been completed and the survey has been finalized. The basis for the use of special tools such as the scale is to prove the usability of the tool in the sample group to which it will be applied. The first step for this is the translation stage from the original language to the other language.
At the stage of translation into Turkish, two experts who knew a good level of English translated the questionnaire from English into Turkish. These translations have been translated back into Turkish by two native speakers of English and distant medical subjects. In addition, these translations were re-examined by the researchers and turned into a single form. This form was sent to five specialists in the field, checking the content and compliance with Turkish was evaluated. With the opinion of experts, the scale was finalized.
The study will include individuals over 40 years of age who have been diagnosed with an ischemic or hemorhagic stroke, who applied to the Kırıkkale University Faculty of Medicine Physical Therapy and Rehabilitation Hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of stroke,
* No cooperation and communication problems
* To be able to walk 10 m independently with or without an auxiliary device
Exclusion Criteria
* Individuals with advanced contraindications for cardiovascular disease and mobilization will not be included in the study.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kırıkkale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kübra Uğurlu
Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saniye Aydoğan Arslan
Role: STUDY_DIRECTOR
Kırıkkale University
Kübra Uğurlu
Role: PRINCIPAL_INVESTIGATOR
Kırıkkale University
Cevher Demirci
Role: PRINCIPAL_INVESTIGATOR
Balikesir University
Zekiye İpek Katırcı Kırmacı
Role: PRINCIPAL_INVESTIGATOR
Sanko University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kırıkkale University
Kırıkkale, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Padgett PK, Jacobs JV, Kasser SL. Is the BESTest at its best? A suggested brief version based on interrater reliability, validity, internal consistency, and theoretical construct. Phys Ther. 2012 Sep;92(9):1197-207. doi: 10.2522/ptj.20120056. Epub 2012 Jun 7.
Smith PS, Hembree JA, Thompson ME. Berg Balance Scale and Functional Reach: determining the best clinical tool for individuals post acute stroke. Clin Rehabil. 2004 Nov;18(7):811-8. doi: 10.1191/0269215504cr817oa.
Schmidt S, Bullinger M. Current issues in cross-cultural quality of life instrument development. Arch Phys Med Rehabil. 2003 Apr;84(4 Suppl 2):S29-34. doi: 10.1053/apmr.2003.50244.
Chinsongkram B, Chaikeeree N, Saengsirisuwan V, Viriyatharakij N, Horak FB, Boonsinsukh R. Reliability and validity of the Balance Evaluation Systems Test (BESTest) in people with subacute stroke. Phys Ther. 2014 Nov;94(11):1632-43. doi: 10.2522/ptj.20130558. Epub 2014 Jun 12.
Bergstrom M, Lenholm E, Franzen E. Translation and validation of the Swedish version of the mini-BESTest in subjects with Parkinson's disease or stroke: a pilot study. Physiother Theory Pract. 2012 Oct;28(7):509-14. doi: 10.3109/09593985.2011.653707. Epub 2012 Jan 30.
O'Hoski S, Sibley KM, Brooks D, Beauchamp MK. Construct validity of the BESTest, mini-BESTest and briefBESTest in adults aged 50 years and older. Gait Posture. 2015 Sep;42(3):301-5. doi: 10.1016/j.gaitpost.2015.06.006. Epub 2015 Jun 25.
Franchignoni F, Horak F, Godi M, Nardone A, Giordano A. Using psychometric techniques to improve the Balance Evaluation Systems Test: the mini-BESTest. J Rehabil Med. 2010 Apr;42(4):323-31. doi: 10.2340/16501977-0537.
Horak FB, Wrisley DM, Frank J. The Balance Evaluation Systems Test (BESTest) to differentiate balance deficits. Phys Ther. 2009 May;89(5):484-98. doi: 10.2522/ptj.20080071. Epub 2009 Mar 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
turkishbriefBESTest
Identifier Type: -
Identifier Source: org_study_id